Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02921412 · ClinicalTrials.gov registry record · NA
Performance of Fanfilcon A Toric Lenses After at Least One Month Wearing Enfilcon A Toric Lenses
A NA study of Astigmatism, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 4
- Study locations
NCT02921412 is a NA study of Astigmatism that has completed, run by CooperVision. The registered enrollment target is 37 participants, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (65% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT02921412, a NA study of Astigmatism, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a prospective, multi-center, subject-masked, bilateral, daily wear, two-month dispensing study
Conditions Studied
Interventions
- DEVICE fanfilcon A
Study Locations (4)
Florida
- Hospital Contact Lens Service - Miami
New Jersey
- Debbie Kim - Closter
New York
- West Village Eyecare - New York
Washington
- Spokane Eye Clinic - Spokane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2017-03-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02921412
The ClinicalTrials.gov registry entry for NCT02921412 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (65% lower). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Astigmatism appearing as the primary indexed condition, and to 1 intervention - of which fanfilcon A is the first listed.
NCT02921412 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT02921412 about?
NCT02921412 is a clinical study titled "Performance of Fanfilcon A Toric Lenses After at Least One Month Wearing Enfilcon A Toric Lenses". This is a prospective, multi-center, subject-masked, bilateral, daily wear, two-month dispensing study
What is the current status of trial NCT02921412?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2016-10-01. Estimated completion is 2017-03-21.
What conditions does trial NCT02921412 study?
This clinical trial studies the following conditions: Astigmatism.
What interventions are being tested in trial NCT02921412?
The interventions under investigation include: fanfilcon A (DEVICE).
Who is sponsoring clinical trial NCT02921412?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02921412 being conducted?
This trial has 4 study locations across Florida, New Jersey, New York, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Astigmatism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery
RECRUITING · NA
-
A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism
RECRUITING · NA
-
Contoura With Phorcides Compared to Wavefront Optimized LASIK
RECRUITING · NA
-
Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction
ACTIVE NOT RECRUITING · NA
-
LASIK iDesign vs SMILE
ACTIVE NOT RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.